These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1383615)

  • 21. Pancreatic polypeptide inhibits amylase release by rat pancreatic acini.
    Joehl RJ; DeJoseph MR
    J Surg Res; 1986 Apr; 40(4):310-4. PubMed ID: 2422440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amylase secretion by isolated pancreatic acini after chronic cholecystokinin treatment in vivo.
    Otsuki M; Williams JA
    Am J Physiol; 1983 Jun; 244(6):G683-8. PubMed ID: 6190411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
    Chowdhury P; Rayford PL
    Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic secretory responses in L-arginine-induced pancreatitis: comparison of diabetic and nondiabetic rats.
    Hegyi P; Czako L; Takacs T; Szilvassy Z; Lonovics J
    Pancreas; 1999 Aug; 19(2):167-74. PubMed ID: 10438164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diet stimulation as a synergistic factor of aggravation in a pancreatic bile duct ligation-induced rat pancreatitis model.
    Yoshinaga K; Washizuka M; Segawa Y
    Biol Pharm Bull; 2000 Nov; 23(11):1318-22. PubMed ID: 11085359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function.
    Hazlett D; Korc M; Brannon PM
    Pediatr Res; 1986 Dec; 20(12):1236-9. PubMed ID: 2432455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of sensitivity to cholecystokinin stimulation of isolated pancreatic acini from genetically diabetic rats.
    Otsuki M; Akiyama T; Shirohara H; Nakano S; Furumi K; Tachibana I
    Am J Physiol; 1995 Mar; 268(3 Pt 1):E531-6. PubMed ID: 7534992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory effects of vanadate on amylase release from isolated rat pancreatic acini.
    Hirohata Y; Ogami Y; Akiyama T; Shibuya I; Otsuki M
    Biochem Pharmacol; 1998 Mar; 55(5):677-85. PubMed ID: 9515578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased pancreatic exocrine response to cholecystokinin in Zucker obese rats.
    McLaughlin CL; Peikin SR; Baile CA
    Am J Physiol; 1982 Jun; 242(6):G612-9. PubMed ID: 6178298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction.
    Barrett TD; Yan W; Freedman JM; Lagaud GJ; Breitenbucher JG; Shankley NP
    Br J Pharmacol; 2008 Apr; 153(8):1650-8. PubMed ID: 18297100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor inhibits rat pancreatic cell proliferation, causes acinar cell hypertrophy, and prevents caerulein-induced desensitization of amylase release.
    Morisset J; Larose L; Korc M
    Endocrinology; 1989 Jun; 124(6):2693-8. PubMed ID: 2470581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
    Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amylase secretion by isolated pancreatic acini after acute cholecystokinin treatment in vivo.
    Otsuki M; Okabayashi Y; Ohki A; Hootman SR; Baba S; Williams JA
    Am J Physiol; 1984 Apr; 246(4 Pt 1):G419-25. PubMed ID: 6326589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of uncoupling NO/cGMP pathways on carbachol- and CCK-stimulated Ca2+ entry and amylase secretion from the rat pancreas.
    Yoshida H; Tsunoda Y; Owyang C
    Pflugers Arch; 1997 May; 434(1):25-37. PubMed ID: 9094253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional changes of rat exocrine pancreas exposed to nicotine.
    Chowdhury P; Doi R; Tangoku A; Rayford PL
    Int J Pancreatol; 1995 Dec; 18(3):257-64. PubMed ID: 8708398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Altered cholecystokinin-induced calcium signal in streptozotocin-induced diabetic rat pancreatic acini].
    Kim MJ; Ryu GR; Sung JH; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jo YH; Kim MS
    Korean J Gastroenterol; 2003 Dec; 42(6):519-26. PubMed ID: 14695709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin-induced secretion and synthesis of amylase and cationic trypsinogen by pancreatic acini isolated from rats given an ethanol diet.
    Tsukamoto H; Kiefer MA; Ananda Rao G; Larkin EC; Largman C; Sankaran H
    Life Sci; 1985 Oct; 37(15):1359-65. PubMed ID: 2413328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of AA861, a 5-lipoxygenase inhibitor, on amylase secretion from rat pancreatic acini.
    Sato S; Adachi H; Noguchi M; Honda T; Onishi S; Aoki E; Torizuka K
    Biochim Biophys Acta; 1988 Jan; 968(1):1-8. PubMed ID: 2447953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.